CapeBio
- Company typePrivate
- Founded2016
- HeadquartersCenturion, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
CapeBio firmographics
Firmographics- Name
- CapeBio
- Legal name
- CapeBio SA
- Website
- https://capebiosa.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
CapeBio industry classification
Industry- Product category
- Biotechnology Reagents and Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where CapeBio is headquartered
LocationHeadquarters
- HQ city
- Centurion
- HQ country
- South Africa
- HQ region
- Africa
Markets served
CapeBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure
CapeBio product offering
Product offeringCore offering
CapeBio manufactures molecular biology research and diagnostic reagents, enzymes, and kits. The company offers custom DNA/RNA oligonucleotide synthesis with HPLC purification, in vitro diagnostic (IVD) solutions for clinical applications, novel enzyme discovery leveraging African biodiversity, and ISO 13485:2016 compliant GMP-validated regulatory manufacturing services for the global research, clinical, and biotechnology innovation markets.
Product overview
CapeBio is a South African biotechnology company offering a portfolio of molecular biology and biomanufacturing products and services. The company operates as a multi-product provider offering four integrated service lines: Oligonucleotide Synthesis (custom DNA/RNA synthesis with HPLC purification), Diagnostic & IVDs (in vitro diagnostic solutions), Enzyme Discovery (leveraging African biodiversity for novel biomolecules), and Regulatory Manufacturing (ISO 13485:2016 compliant GMP operations). The company emphasizes integration of state-of-the-art laboratories, AI-assisted bioinformatics, and highly trained personnel across its product and service offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Oligonucleotide Synthesis
Companies that use CapeBio
Customer profileSegments3 records
Ideal customer profiles1 record
CapeBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CapeBio partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
CapeBio competitors and assessment
Company assessmentBroad incumbents
- QIAGEN: QIAGEN is a global leader in molecular biology reagents and IVD sample-prep technologies, serving clinical and research customers in infectious disease and molecular diagnostics — overlapping with CapeBio's IVD and oligo ambitions.
- Bio-Techne: Bio-Techne is a large, diversified life-science reagents and diagnostics company with deep catalogs across proteins, antibodies, and molecular biology — competing with CapeBio across multiple of its four product lines from a much broader portfolio.
- Thermo Fisher Scientific: Thermo Fisher is the dominant broad incumbent across life-science reagents, custom oligos, and IVD manufacturing — a benchmark competitor that pressures CapeBio on price, scale, and established global distribution.
Direct peers
- Eurofins Genomics: Eurofins Genomics offers custom oligo synthesis, DNA sequencing services and molecular biology reagents across global markets, overlapping directly with CapeBio's oligonucleotide and genomics-adjacent service lines.
- Macrogen: Macrogen is a long-standing DNA sequencing and oligonucleotide service provider with a global footprint, offering custom oligos and molecular biology reagents in a similar positioning to CapeBio's research-services business.
- Synbio Technologies: Synbio Technologies provides custom DNA/RNA oligo synthesis, gene synthesis and molecular biology services with a comparable mid-sized scale and a similar focus on serving both research and clinical/IVD customers.
- Bioneer: Bioneer is a mid-sized Korean molecular biology company offering oligos, enzymes, and IVD reagents for global research and clinical markets, with a similar scale and multi-product positioning to CapeBio.
- Twist Bioscience: Twist Bioscience operates a high-throughput DNA synthesis platform serving synthetic biology, diagnostics, and academic research — a close technology and use-case peer to CapeBio's DNA/RNA manufacturing line.
- Integrated DNA Technologies (IDT): IDT is the global benchmark in custom oligonucleotide synthesis and a leader in DNA/RNA reagents for research and clinical applications — directly comparable to CapeBio's oligonucleotide synthesis core product.
- LGC Biosearch Technologies: LGC Biosearch Technologies provides custom oligonucleotide synthesis and molecular biology reagents for genomics and diagnostics customers globally, directly comparable to CapeBio's custom DNA/RNA offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CapeBio social profiles
Digital presenceCapeBio compliance and trust
Trust signalCompliance1 record
CapeBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
CapeBio leadership team
Management profileNumber of profiles
CapeBio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CapeBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CapeBio
What does CapeBio do?
CapeBio manufactures molecular biology research and diagnostic reagents, enzymes, and kits. The company offers custom DNA/RNA oligonucleotide synthesis with HPLC purification, in vitro diagnostic (IVD) solutions for clinical applications, novel enzyme discovery leveraging African biodiversity, and ISO 13485:2016 compliant GMP-validated regulatory manufacturing services for the global research, clinical, and biotechnology innovation markets.
Is CapeBio a public or private company?
CapeBio is a private company. It is classified as venture growth investor backed and is currently operating.
When was CapeBio founded?
CapeBio was founded in 2016. It employs 11 to 50 people.
Where is CapeBio based?
CapeBio is headquartered in Centurion, South Africa, in the Africa region.
Who are CapeBio's main competitors?
Broad incumbents on record are QIAGEN, Bio-Techne and Thermo Fisher Scientific. Direct peers are Eurofins Genomics, Macrogen, Synbio Technologies, Bioneer, Twist Bioscience, Integrated DNA Technologies (IDT) and LGC Biosearch Technologies.
Does CapeBio have an API?
No public API is recorded for CapeBio.
What industry is CapeBio in?
CapeBio's product category is Biotechnology Reagents and Diagnostics. Its primary akta.pro industry code is HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 325413 and its SIC code is 2835.